ALIGOS THERAPEUTICS
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.
ALIGOS THERAPEUTICS
Industry:
Biotechnology
Founded:
2018-04-12
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.aligos.com
Total Employee:
51+
Status:
Active
Total Funding:
400.6 M USD
Technology used in webpage:
IPv6 Common Name Invalid ReCAPTCHA V2 Pinterest Google Adsense AddThis Akamai Hosted Google Plus One Platform Google Adsense Asynchronous Ads.txt
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Fountain Therapeutics
Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Employees Featured
Lawrence Blatt Chief Executive Officer & Founder @ Aligos Therapeutics
Chief Executive Officer & Founder
2018-03-01
Leonid Beigelman President and Founder @ Aligos Therapeutics
President and Founder
Meenakshisundaram Venkatraman Senior Director, CMC @ Aligos Therapeutics
Senior Director, CMC
2020-01-01
Lucinda Quan Co-Founder & Advisor @ Aligos Therapeutics
Co-Founder & Advisor
2024-01-01
Founder
Stock Details
Investors List
Deep Track Capital
Deep Track Capital investment in Post-IPO Equity - Aligos Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Aligos Therapeutics
Armistice Capital
Armistice Capital investment in Post-IPO Equity - Aligos Therapeutics
Lawrence Blatt
Lawrence Blatt investment in Post-IPO Equity - Aligos Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Post-IPO Equity - Aligos Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Aligos Therapeutics
Vivo Capital
Vivo Capital investment in Series B - Aligos Therapeutics
Novo Holdings
Novo Holdings investment in Series B - Aligos Therapeutics
Logos Capital
Logos Capital investment in Series B - Aligos Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Series B - Aligos Therapeutics
Official Site Inspections
http://www.aligos.com Semrush global rank: 3.69 M Semrush visits lastest month: 3.34 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aligos Therapeutics"
Overview - ALIGOS Therapeutics
Founded in 2018 and headquartered in South San Francisco, California, Aligos is a clinical-stage biotechnology company that was founded with the mission to become a leader in the treatment of liver and viral diseases. As hepatologists …See details»
Overview - ALIGOS Therapeutics
News Releases Jun 05, 2024 Aligos Therapeutics Presents Positive Data at the EASL Congress 2024 May 22, 2024 Aligos Therapeutics Announces Six Abstracts Accepted for Presentation …See details»
CORPORATE PRESENTATION - investor.aligos.com
Aligos Development Portfolio 3 *Our Covid-19 protease inhibitor programs are partly funded (>$12M USD awarded) by the NIH and NIAID’s AViDD Centers for Pathogens of Pandemic …See details»
Aligos Therapeutics - Crunchbase Company Profile
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of …See details»
Aligos Therapeutics, Inc. - AnnualReports.com
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral diseases. Aligos’ strategy is to harness the deep expertise and …See details»
Aligos Therapeutics Reports Recent Business Progress and First …
May 7, 2024 Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral …See details»
Corporate Governance Guidelines[1] - investor.aligos.com
Any position on the board of directors of any organization, whether for-profit or not-for-profit, current directors should notify the Nominating and Corporate Governance Committee. The …See details»
Management - ALIGOS Therapeutics
We are a group of accomplished professionals across the drug discovery and development landscape driven by the need for better patient outcomes.See details»
Aligos Therapeutics, Inc.'s (NASDAQ:ALGS) biggest owners are …
Dec 21, 2024 A look at the shareholders of Aligos Therapeutics, Inc. (NASDAQ:ALGS) can tell us which group is most powerful. The group holding the most number of shares in the …See details»
Aligos Therapeutics Inc, 5WK0:STU profile - FT.com - Financial Times
3 days ago Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases. The …See details»
A Brief History of Aligos Therapeutics
Nov 29, 2024 Founding and Origins of Aligos Therapeutics. Aligos Therapeutics was founded in [year] by a team of experienced scientists and entrepreneurs with a shared vision of …See details»
Aligos Therapeutics Announces $92 Million Private Placement …
Oct 23, 2023 Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral …See details»
Lawrence M. Blatt, Ph.D. Chairman, CEO & Co-FounderC - ALIGOS …
To the business of Aligos Therapeutics in general, see Aligos’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 4, 2021, and its future periodic …See details»
Aligos Therapeutics Announces U.S. FDA Clearance of IND
Oct 22, 2024 Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184 Provided by GlobeNewswire Oct 22, 2024 12:00pm. ... according to the World Health …See details»
Lawrence M. Blatt, Ph.D. Chairman, CEO & Co-FounderC - ALIGOS …
Jul 14, 2021 to the business of Aligos Therapeutics in general, see Aligos’ prospectus filed with the Securities and Exchange Commission on July 1, 2021, and its ... World Health …See details»
Aligos Therapeutics Presents Positive Clinical Data at Hep-DART …
Dec 7, 2023 Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of liver and viral …See details»
Aligos Therapeutics (ALGS) Earnings Date and Reports 2025
Aligos Therapeutics announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$3.07, which missed the consensus estimate of -$2.15 by $0.92. Quarterly revenue was …See details»
Pipeline - ALIGOS Therapeutics
ALG-055009 was designed by Aligos to be a potent best-in-class oral, small molecule thyroid receptor beta agonist (THR-β) for the treatment of metabolic dysfunction-associated …See details»
Aligos Therapeutics to Present Nonclinical Data for All …
Aug 27, 2020 SOUTH SAN FRANCISCO, Calif., August 27, 2020 – Aligos Therapeutics, Inc. (Aligos), a private biopharmaceutical company focused on developing novel therapeutics to …See details»
Aligos Therapeutics Presents Positive Data at The Liver Meeting …
Nov 19, 2024 SOUTH SAN FRANCISCO, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company …See details»